Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Photocure ASA of Norway (2017 sales of 150.91 million Norwegian Kroner [US$17.82 million] of which 57% was Hexvix/Cysview Own Sales), Science In Sport Plc of the United Kingdom (£15.62 million [US$19.89 million] of which 89% was Core), and Replek AD Skopje which is based in Macedonia (955.23 million Denar [US$17.70 million] ).

Sales Analysis. During the year ended December of 2017, sales at Pierrel were 16.84 million Euro (US$19.22 million). This is an increase of 18.0% versus 2016, when the company's sales were 14.27 million Euro.